Rossmore Private Capital’s Celgene Corp CELG Stock Holding History

Rossmore Private Capital’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5,475	Closed	-$544K	–	139
2019 Q3	$544K	Buy	5,475 +3,000	+121%	+$285K	0.18%	82
2019 Q2	$229K	Hold	2,475	–	–	0.08%	124
2019 Q1	$233K	Buy	+2,475	New	+$216K	0.09%	116
2018 Q4	–	Sell	-4,625	Closed	-$414K	–	137
2018 Q3	$414K	Buy	+4,625	New	+$409K	0.17%	86
2018 Q2	–	Sell	-2,975	Closed	-$265K	–	119
2018 Q1	$265K	Buy	2,975 +609	+26%	+$58.5K	0.27%	79
2017 Q4	$247K	Buy	+2,366	New	+$267K	0.25%	78

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Rossmore Private Capital's CELG Position: Q4 2019 in Review

Rossmore Private Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 5,475 shares — an estimated $544K sold.

Rossmore Private Capital first reported a position in CELG in Q4 2017 and held it in 6 quarters. The position peaked at $544K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Rossmore Private Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Rossmore Private Capital sold 5,475 Celgene Corp shares in Q4 2019, an estimated $544K.
Rossmore Private Capital first reported a position in Celgene Corp in Q4 2017 and held it in 6 quarters.
Rossmore Private Capital's Celgene Corp position peaked at $544K in Q3 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Rossmore Private Capital's 13F filing for Q4 2019, filed 10 Feb 2020.